Johnson And Johnson Aktie - JNJ

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

130,04

Gebot

129,72

Fragen

130,10

Volumen

11.604

129,32 Tagesbereich 131,66

128,02 52-Wochen-Bereich 161,48

Marktkapitalisierung

312,886B

Handelsende

130,90

Handelsbeginn

131,20

Letzte Trade

130.13999

Letzter Handelszeitpunkt

Finanzvolumen

VWAP

Durchschnittliches Volumen (3 Mio.)

13.039

Ausgegebene Aktien

2.406.073.279

Dividendenrendite

4.61%

Kurs-Gewinn-Verhältnis

25,62

Gewinn pro Aktie (EPS)

5,85

Erlöse

88,82B

Nettogewinn

14,07B

Sektor

Pharmaceutical Preparations

Branche

Pharmaceutical Preparations

Website

www.jnj.com

Hauptsitz

New Brunswick, New Jersey, USA

Gegründet

Johnson And Johnson is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker JNJ. The last closing price for Johnson And Johnson was 130,90 €. Over the last year, Johnson And Johnson shares have traded in a share price range of 128,02 € to 161,48 €.

Johnson And Johnson currently has 2.406.073.279 shares in issue. The market capitalisation of Johnson And Johnson is 314,95 € billion. Johnson And Johnson has a price to earnings ratio (PE ratio) of 25.62.

Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference

NEW BRUNSWICK, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in the RBC Capital Markets' Health Care Conference on...

Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

Cordis to Receive $1.725 Billion BRIDGEWATER, N.J., Feb. 1 /PRNewswire/ -- Cordis Corporation, a Johnson & Johnson company, announced today that...

Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results:

2009 Fourth-Quarter Sales of $16.6 Billion increased 9.0%; EPS was $0.79 2009 Full-Year Sales of $61.9 Billion decreased 2.9%; Full-Year EPS was...

Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2009 Financial Results

NEW BRUNSWICK, N.J., Jan. 19 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday...

Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (ri

TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly...

Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses

ORLANDO, Fla., Nov. 11 /PRNewswire-FirstCall/ -- Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear...

VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmolo

Telescope Prosthesis for End-Stage Macular Degeneration Highlighted SARATOGA, Calif., Oct. 20 /PRNewswire/ -- VisionCare Ophthalmic Technologies...

New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

Patients with Active Rheumatoid Arthritis Receiving SIMPONI Demonstrated Sustained Improvements in Signs and Symptoms Through One Year...

New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Results from Radiographic Analyses Show Efficacy of SIMPONI in Inhibiting Joint Destruction in Two Rheumatic Conditions PHILADELPHIA, Oct. 19...

Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Bu

NEW BRUNSWICK, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-4.14	-3.08540766135	134.18	136.9	129.32	6137	133.27273918	DE
4	-4.96	-3.67407407407	135	137.88	129.32	7099	135.03326742	DE
12	-21.04	-13.9263966111	151.08	154.1	128.02	13039	137.63608794	DE
26	-8.48	-6.12185965925	138.52	161.47999	128.02	12068	142.87171089	DE
52	-5.7	-4.19920436128	135.74	161.47999	128.02	10207	143.6575337	DE
156	-31.06	-19.2799503414	161.1	178.26	128.02	7254	146.1066249	DE
260	1.02	0.790575104635	129.02	178.26	116.12	7473	142.17647404	DE

JNJ - Frequently Asked Questions (FAQ)

What is the current Johnson And Johnson share price?

The current share price of Johnson And Johnson is 130,04 €

How many Johnson And Johnson shares are in issue?

Johnson And Johnson has 2.406.073.279 shares in issue

What is the market cap of Johnson And Johnson?

The market capitalisation of Johnson And Johnson is EUR 314,95B

What is the 1 year trading range for Johnson And Johnson share price?

Johnson And Johnson has traded in the range of 128,02 € to 161,48 € during the past year

What is the PE ratio of Johnson And Johnson?

The price to earnings ratio of Johnson And Johnson is 25,62

What is the cash to sales ratio of Johnson And Johnson?

The cash to sales ratio of Johnson And Johnson is 4,06

What is the reporting currency for Johnson And Johnson?

Johnson And Johnson reports financial results in USD

What is the latest annual turnover for Johnson And Johnson?

The latest annual turnover of Johnson And Johnson is USD 88,82B

What is the latest annual profit for Johnson And Johnson?

The latest annual profit of Johnson And Johnson is USD 14,07B

What is the registered address of Johnson And Johnson?

The registered address for Johnson And Johnson is ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NEW JERSEY, 08933

What is the Johnson And Johnson website address?

The website address for Johnson And Johnson is www.jnj.com

Which industry sector does Johnson And Johnson operate in?

Johnson And Johnson operates in the PHARMACEUTICAL PREPARATIONS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
WS90Provaris Energy Ltd	0,011 € (61,76%)	2,66M
XABNetlist Inc Dl 001	0,84 € (37,70%)	90,68k
47FLQWD Technologies Corp	2,72 € (36,00%)	16,17k
EJ7Energy Resources of Australia	0,002 € (33,33%)	1M
E3O1Nexoptic Technology Corp	0,0105 € (31,25%)	13,52k
PHPNGalectin Therapeutics Inc	1,82 € (-36,36%)	12,69k
1SSNextech3d Ai Corp	0,0118 € (-32,95%)	281
EUSKore Mining Ltd	0,015 € (-28,57%)	9k
PU11Social Chain AG	0,0145 € (-27,50%)	10
M13VERSES AI Inc	3,30 € (-27,02%)	34,68k
E3BEutelsat Communications	3,59 € (26,63%)	5,86M
WS90Provaris Energy Ltd	0,011 € (61,76%)	2,66M
D7GNel ASA	0,2076 € (1,47%)	2,18M
3WUFreeman Gold Corp	0,0975 € (5,41%)	2,15M
Z620Trillion Energy International Inc	0,0395 € (1,80%)	2,05M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Johnson And Johnson (JNJ)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Johnson And Johnson

JNJ Neueste Nachrichten

Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference

Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results:

Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2009 Financial Results

Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (ri

Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses

VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmolo

New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Bu

JNJ - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Johnson And Johnson (JNJ) Börsenkurse

Johnson And Johnson (JNJ)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über Johnson And Johnson

JNJ Neueste Nachrichten

Johnson & Johnson to Participate in RBC Capital Markets' Health Care Conference

Cordis Corporation Announces Agreement With Boston Scientific To Resolve Certain Coronary Stent Patent Disputes

Johnson & Johnson Reports 2009 Fourth-Quarter and Full-Year Results:

Johnson & Johnson to Host Analyst Meeting to Discuss Fourth-Quarter and Full-Year 2009 Financial Results

Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (ri

Longer Prescribed Replacement Intervals Leads to More Stretching of Frequent Replacement Contact Lenses

VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmolo

New SIMPONI(TM) Data Show Long-Term Efficacy in Treatment of Rheumatoid Arthritis

New SIMPONI(TM) Data Show Inhibition of Joint Damage in Patients With Rheumatoid Arthritis and Psoriatic Arthritis

Johnson & Johnson to Host Analyst Meeting to Discuss Third-Quarter Financial Results and Review Medical Devices & Diagnostics Bu

JNJ - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Anmelden

Werbung entfernen